Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 23, Number 2—February 2017

CME ACTIVITY - Research

Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel

Ronen Ben-AmiComments to Author , Judith Berman, Ana Novikov, Edna Bash, Yael Shachor-Meyouhas, Shiri Zakin, Yasmin Maor, Jalal Tarabia, Vered Schechner, Amos Adler, and Talya Finn
Author affiliations: Tel Aviv University, Tel Aviv, Israel (R. Ben-Ami, J. Berman, S. Zakin, Y. Maor, V. Schechner, A. Adler); Tel Aviv Sourasky Medical Center, Tel Aviv (R. Ben-Ami, A. Novikov, E. Bash, J. Tarabia, V. Schechner, A. Adler, T. Finn); Ruth Rappaport Children's Hospital, Haifa, Israel (Y. Shachor-Meyouhas); Wolfson Medical Center, Holon, Israel (Y. Maor).

Main Article

Table 2

Comparison of colonized and noncolonized patients with Candida haemulonii, clinic A, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel*

p value Odds ratio (95% CI) Controls, n = 40 Cases, n = 20 Variable
0.015 NA 63.0 (43–94) 77.5 (44–91) Median age, y (range)
0.017 6.65 (1.26–65.0) 23 (57.5) 18 (90) Male sex
0.44 NA 48 (9–192) 40 (8–228) Median time in clinic A, mo (range)
0.022 NA 62.9 ± 3.61 47.7 ± 5.56 eGFR, mL/min/1.73m2, mean ± SEM
0.057 3.05 (0.88–11.2) 15 (37.5) 13 (65) Chronic kidney disease, stage 3–4
0.069 3.85 (0.76–21.0) 4 (10) 6 (30) Dialysis
0.003 5.5 (1.51–21.1) 10 (25) 13 (65) Ischemic heart disease
0.27 2.05 (0.59–7.37) 19 (47.5) 13 (65) Diabetes mellitus
1.00 0.80 (0.13–5.84) 35 (87.5) 17 (85) Peripheral vascular disease

*Values are no. (%) patients except as indicated. eGFR, glomerular filtration rate, estimated using the Modification of Diet in Renal Disease (MDRD) equation (22); NA, odds ratio is not applicable for continuous variables.

Main Article

TOP